Page 20 - Soc Gen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

A lack of stats from the Eurozone and an early close for the CAC40 leaves China PMI numbers and updates from Capitol Hill in focus.

It's a quiet day on the economic calendar, which will leave Brexit and U.S stimulus in focus on the day.

Advertisement Start Trading Advertisement The Majors It was another bullish day for the European majors on Thursday, with the DAX30 rising by 0.75% to lead the way yet again. The CAC40 and the EuroStoxx600, once more, saw more modest gains of 0.03% and 0.30% respectively. Following positive private sector PMI numbers on Wednesday, COVID-19 vaccine news delivered support on the day. Progress on Capitol Hill towards a stimulus package was also positive for the European majors on the day. On the vaccine front, both France and Germany announced that vaccinations would likely commence in the final...

Advertisement The Majors It was a bullish day for the European majors on Wednesday, with the DAX30 rising by 1.52% to lead the way once more. The CAC40 and the EuroStoxx600 saw more modest gains of 0.31% and 0.82% respectively. With the EMA bringing forward the BioNTech/Pfizer Inc. vaccine review, hopes of a Brexit deal were also market positive. Key on the day, however, was a recovery in private sector activity across France, Germany, and the Eurozone. In spite of a reintroduction of lockdown measures, manufacturing sector PMI numbers impressed in particular, easing market concerns over the ...

Advertisement The Majors It was a bullish day for the European majors on Tuesday, with the DAX30 rising by 1.06% to lead the way. The CAC40 and the EuroStoxx600 saw more modest gains of 0.04% and 0.25% respectively. Progress on the COVID-19 vaccine front offset negative sentiment towards a reintroduction of containment measures. Following news of Germany set for another lockdown, news hit the wires on Tuesday of a likely partial lockdown in Italy. Hopes of the EMA approving the BioNTech/Pfizer Inc. and Moderna Inc. vaccines in mid-January muted the impact of the lockdown news. The Stats It wa...